Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): Eczema diagnostic patch 02 drug clinical trial application accepted.

17:41 04/03/2025

WuXi Biologics (300357.SZ) announced that the company has received a "Notice of Acceptance" issued by the National Medical Products Administration...

Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) announced that the company has received an "Acceptance Notice" from the National Medical Products Administration for the drug clinical trial application submitted by the company for the "Eczema Diagnostic Patch 02 Patch". The related indication is: used for patch testing, assisting in the diagnosis of allergic contact dermatitis related to cortisone, paraphenylenediamine, and formaldehyde sensitization.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.